Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

bioinformatics

This page shows the latest bioinformatics news and features for those working in and with pharma, biotech and healthcare.

Digital shakeout

Digital shakeout

As well as the examples above, we see drug design enabled by bioinformatics, diagnostic imaging enabled by AI, blood sugar monitoring uploaded to the cloud and a thousand other ways that

Latest news

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Accelerating innovation Accelerating innovation

    modelling and simulations, and developing the expertise required in areas such as predictive toxicology and bioinformatics.

  • Digital disruption Digital disruption

    strategy lead, Bioinformatics, Oncology, Innovative Medicines and Early Development (IMED) at AstraZeneca.

  • Deal Watch January 2017 Deal Watch January 2017

    Merck KGaA / Palantir. Combining Merck's research with other bioinformatics for patient sub group identification.

  • Opening up innovation Opening up innovation

    with the European Bioinformatics Institute and the Sanger Institute. “

  • Under pressure Under pressure

    It is based on technologies, such as bioinformatics, gene sequencing, biomarkers and synthetic biology that make systems biology and systems medicine possible.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Former GSK CEO joins Synthego’s advisory board Former GSK CEO joins Synthego’s advisory board

    Former GSK CEO joins Synthego’ s advisory board. Sir Andrew Witty will expand the team’s bioinformatics expertise. ... industry. “This is part of the next step in bringing Synthego’s bioinformatics and experimental expertise to new applications

  • Global Gene Corp appoints new chief data and technology officer Global Gene Corp appoints new chief data and technology officer

    Turpaz brings over 17 years of experience across bioinformatics, IT, pharmaceuticals, digital health and genomics, most recently serving as chief information officer for Human Longevity (HLI), where he led the development

  • Repositive appoints scientific lead Repositive appoints scientific lead

    Prior to this, he held a number of roles at the European Bioinfomatics Institute, Sanger and the Spanish National Bioinformatics Centre.

  • European bioinformatics institute appoints GSK's Dr Andrew Leach European bioinformatics institute appoints GSK's Dr Andrew Leach

    European bioinformatics institute appoints GSK's Dr Andrew Leach. He joins the EMBL-EBI as head of chemistry services. ... The European Bioinformatics Institute (EBI) has appointed Dr Andrew Leach as head of chemistry services, who will take up the

  • Bioinformatics firm Eagle adds to senior team Bioinformatics firm Eagle adds to senior team

    Bioinformatics firm Eagle adds to senior team. Appoints Michael Reynolds and promotes Will Spooner and Glenn Proctor. ... Meanwhile, Proctor - who previously led the software development of Ensembl at the European Bioinformatics Institute - will be

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Packer Forbes News January 2016

    Her dissertation describes the characteristics of dendritic cells and their role in HIV and she also completed a bioinformatics project analysing the sensorimotor system in rodents.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Quick links

Infographics

Multimedia